Objectives To our knowledge no previous study has assessed the performance of a rapid
antigen diagnostic immunoassay (RAD) conducted at the point of care (POC). We evaluated …

From a quantitative standpoint (Table 2), although both CMV-specific CD4 SP+ sp and CD8
SP+ sp T cells tended to fluctuate regardless of the therapy the patients received and varied …

All CMV DNAemia episodes cleared spontaneously, and no patients developed either
recurrent CMV DNAemia or CMV end-organ disease within the study period. Enumeration of …

It is unknown whether Torque Teno virus (TTV) DNA load monitoring could anticipate the
development of infectious events in hematological patients undergoing treatment with small …

Assessment of commercial severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
immunoassays for their capacity to provide reliable information on sera neutralizing activity …

To the Editor, Serological testing is increasingly recognized as a useful tool for management
of the coronavirus disease‐2019(COVID‐19) pandemic. 1 Cross‐sectional serosurveys …

We evaluated the Panbio™ COVID-19 AG Rapid Test Device (RAD) for the diagnosis of
COVID-19 in symptomatic patients attended in primary healthcare centers (n=412). Overall …

Background We investigated whether donor‐recipient mismatch involving one or more
cytomegalovirus (CMV) immunodominant (ID) human leukocyte antigen (HLA)‐I alleles may …

Cytomegalovirus (CMV) DNAemia may develop in a large percentage (up to 45%) of CMV-seropositive
patients undergoing CD19-directed chimeric antigen receptor T-cell therapy [1, 2…

Torque Teno Virus (TTV) is a single-stranded circular DNA virus which has been identified as
a surrogate marker of immune competence in transplantation. In this study we investigated …